BioStem Technologies Granted Prioritized Examination for Wound Healing Patent
May 06, 2024 08:00 ET
|
Biostem Technologies
BioStem Technologies Granted Prioritized Examination for Wound Healing Patent
Fulcrum Therapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Monday, May 13, 2024, at 8:00 a.m. ET
May 06, 2024 08:00 ET
|
Fulcrum Therapeutics, Inc.
CAMBRIDGE, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to...
Omega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
May 06, 2024 07:00 ET
|
Omega Therapeutics
Advanced MYCHELANGELO™ I trial dose escalation to Cohort 5; Presentation of additional monotherapy data and planned expansion into Phase 2 settings expected in mid-2024Presented new preclinical data...
Final Days to Register for the 7th Annual Digi-Tech Pharma & AI Conference: London, United Kingdom - May 28-29, 2024
May 06, 2024 04:03 ET
|
Research and Markets
Dublin, May 06, 2024 (GLOBE NEWSWIRE) -- The "Digi-Tech Pharma & AI 2024" conference has been added to ResearchAndMarkets.com's offering. The 7th Annual Digi-Tech Pharma & AI conference, a...
Plant Growth Regulators Market Size & Share, Growth Analysis, Opportunities and Future Developments
May 06, 2024 04:00 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, May 06, 2024 (GLOBE NEWSWIRE) -- Plant growth regulators (PGRs) are natural or synthetic compounds that can influence various aspects of plant growth and development. They act as chemical...
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 03, 2024 16:05 ET
|
Taysha Gene Therapies, Inc.
DALLAS, May 03, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the...
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 03, 2024 16:01 ET
|
Verve Therapeutics
BOSTON, May 03, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing...
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
May 03, 2024 13:48 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 3 May 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons...
Global Aerospace's SM4 Aviation Safety Program Offers Insights on if ChatGPT is the Ultimate Tool for Safety Management
May 03, 2024 13:44 ET
|
Global Aerospace SM4 Aviation Safety Program
Morris Plains, May 03, 2024 (GLOBE NEWSWIRE) -- There are many articles and blogs about how ChatGPT, an AI language model by OpenAI, assists with brainstorming, problem-solving, reporting and...
Biomea Fusion Reports First Quarter 2024 Financial Results and Corporate Highlights
May 02, 2024 16:05 ET
|
Biomea Fusion, Inc.
Reported positive data from the escalation portion of Phase 1/2 study (COVALENT-111) in type 2 diabetes patients, displaying durable improved glycemic control while off therapy for 22 weeks,...